 |
Evening Primrose
Oil
A Supplement for Health
and Beauty
Author: Tori Hudson, ND
Source: Bioriginal Publishing
Date Published: October 2000
The evening primrose plant
(Oenothera biennis) has been commonly known as "tree primrose" and "sun
drop". Evening primrose can be found in many parts of North America
and is native in the north temperate zone, especially at high altitudes.
The native people of North America as well as the English and pilgrims,
were well aware of the healing properties of the leaves and bark as
an astringent, sedative and nervine (a herb that affects the nerves
and includes relaxants, tonics and even stimulants). It was often used
for stomach and liver complaints, coughs and female disorders. Even
the roots were eaten as a vegetable. The seeds were recommended as a
coffee substitute in wartime and have a strong flavor similar to poppy
seed oil. The therapeutic value of the seed oil is a more recent discovery.
It is this seed oil, and its essential fatty acid content, that holds
the most interest today in maintaining health and preventing disease.
Evening primrose oil is an
oil rich in essential fatty acids polyunsaturated fats that are as
essential as vitamins and minerals for the maintenance of good health.
The oil contains 74 percent linolenic acid (LA) and 8-10 percent gamma
linolenic acid (GLA). Although other oils such as borage oil and black
currant oil contain higher amounts of GLA, evening primrose oil is by
far the most popular and familiar source of this fatty acid. Evening
primrose oil also contains 11 percent oleic acid, 6 percent palmitic
acid, and 2 percent stearic acid.
Under ideal conditions, the
body uses LA to produce GLA. In turn, GLA is used to produce beneficial
hormone-like compounds called prostaglandins. Specifically, GLA is used
to produce series one prostaglandins such as prostaglandin E1 (PGE1).
Prostaglandins affect the
function of virtually every system in the body these molecules are
used in the regulation of inflammation, pain, blood pressure, fluid
balance, and blood clotting. Prostaglandins also affect hormone production
and function.
The key to understanding
the important need for supplementing with oils rich in GLA, such as
evening primrose oil, is that many of us cannot convert LA to GLA efficiently.
Dietary deficiencies, disease conditions, processed oils, trans fatty
acids, heated oils, alcohol, aging, viral infections and sugar consumption
block, slow down, or interfere with the enzyme that catalyzes the conversion
of LA to GLA. The result is that virtually all North Americans are deficient
in GLA. Supplementing with evening primrose oil can enrich the bodyıs
GLA supply and restore the production of beneficial prostaglandins derived
from GLA. Research completed over the last 20 years has confirmed that
supplementation with evening primrose oil has beneficial effects in
numerous diseases and conditions.
Health problems supported
and/or suggested by scientific trials using evening primrose oil include
premenstrual syndrome, fibrocystic breast pain, eczema, rheumatoid arthritis,
diabetes, heart disease, osteoporosis and ulcerative colitis. Other
conditions for which it may provide benefit include menopause and pregnancy.
Prementrual Syndrome
PMS has been linked to excessive and incorrect prostaglandin production.
Women with PMS may have a deficiency of prostaglandin E1 at the central
nervous system1 and in other tissue such as breast tissue. Supplementing
with GLA may raise the bodyıs production of this prostaglandin. The
most popular and scientifically documented method is to supplement with
GLA in the form of evening primrose oil. Rigorous scientific studies
have demonstrated that supplementing with evening primrose oil has a
significant effect on symptoms of PMS.2, 3, 4 Evening primrose oil has
been shown to improve symptoms including premenstrual headaches, depression,
irritability, and bloating. Evening primrose oil also dramatically relieves
premenstrual breast pain and tenderness.
Breast Health
The pain and tenderness associated with premenstrual breast pain and
fibrocystic breasts has been alleviated with evening primrose oil in
more than one scientific study.5, 6 In 1985, when 291 women took three
grams per day of evening primrose oil for three to six months, almost
half of the 92 women with cyclic breast pain experienced improvement
compared with one-fifth of the patients who received the placebo. In
the course of treatment, it has been detected that women with breast
pain have unusually low concentrations of GLA and metabolites from GLA.
When patients receive supplements of evening primrose oil, the concentration
of GLA metabolites increases and the concentration of saturated fats
in the breast decreases. This may also have long term implications for
prevention of breast diseases such as breast cancer.
Menopause
Evening primrose oil and other
oils containing GLA are popularly consumed by women to decrease the
symptoms of menopause. GLA in the form of evening primrose oil has been
found to reduce the maximum number of nighttime flushes associated with
menopause. However, there was no overall difference between the supplement
and the placebo.7 Many other herbal supplements are available to relieve
menopausal symptoms and these may be used in conjunction with EFAs for
greater benefit.
Pregnancy and Fetal Development
Essential fatty acids have a unique role during pregnancy because
of the rapid development of new cell growth, new tissues, and new organ
systems in a developing fetus. Fetal development is associated with
a high EFA requirement, and this supply is dependent on the amount and
availability of EFAs from the mother.
Prostaglandins are also involved
in the development and clinical expression of pre-eclampsia (the simultaneous
occurrence of the clinical triad of hypertension, edema and protein
in the urine at any time during the course of the pregnancy). These
prostaglandins are modulators of vascular smooth muscle tone and platelet
aggregation (blood platelets sticking together). Pre-eclampsia is characterized
by increased vasoconstriction, frequently associated with increased
platelet aggregation, reduced uteroplacental blood flow, and premature
delivery. In a placebo-controlled clinical trial, a group of pregnant
women receiving a combination of evening primrose oil and fish had a
significantly lower incidence of edema.8
Skin Health
Nutritional supplementation with GLA is one of the most important tools
in treating eczema. GLA also helps moisturize the skin and protect it
from environmental oxidative damage. There have been many scientific
studies using GLA with excellent benefits in improving the symptoms
of eczema.9, 10, 11, 12 Dosages in the range of 0.5 to 3 grams of GLA
are appropriate. Both evening primrose oils and borage oil have been
used in these studies.
Arthritis
Many studies on GLA have shown that individuals with rheumatoid arthritis
experience significant improvements in their symptoms within the first
six months of use. They also continue to improve by as much as 50 percent
in the number of tender joints, 54 percent in the reduction of tender
joints, and 42 percent in the reduction in swollen joints. Overall,
morning stiffness can decrease on average by 67 percent, and pain can
be reduced on average by 27 percent.13, 14 Studies using evening primrose
oil also consistently show that individuals using 1.5 to 2.8 grams of
GLA daily can reduce their use of nonsteroidal anti-inflammatory medications.
Although there have been
no human trials to date studying the effects of GLA on other forms of
arthritis such as osteoarthritis, animal studies do show that GLA supplementation
can have anti-inflammatory effects. Practitioners of natural medicine
report that they see positive benefits using evening primrose oil supplements
in osteoarthritis as well as rheumatoid arthritis.
Diabetes
Diabetes is associated with abnormalities in essential fatty acid metabolism.
One of these abnormalities is an impairment in the conversion of LA
to GLA. By supplementing with GLA in the form of evening primrose oil,
we can bypass this impairment and give the body the GLA it needs. Individuals
with diabetic related neuropathies have been studied using GLA. Significant
favorable changes have been observed in muscle strength, hot and cold
thresholds, sensation, and reflexes.15
Heart Disease
High cholesterol: Although fish oils and flax oil have received
considerable attention for their role in reducing heart disease due
to their effects on blood lipids and blood pressure, we shouldnıt forget
about the role of other essential fatty acids. For example, supplementing
with 3 grams of GLA daily for four months has been shown to decrease
triglyceride levels by 48 percent, increase HDL ("good" cholesterol)
by 22 percent, and significantly reduce total cholesterol and LDL ("bad"
cholesterol).16 We should always include evening primrose oil supplementation
in our heart disease treatment and prevention plans in addition to other
EFA oils.
High blood pressure: High blood pressure (a reading above 140/90)
is another risk factor for heart disease. More than 60 double-blind
studies have demonstrated that either fish oil supplements or flaxseed
oil are effective in lowering blood pressure. Again, we would be wise
not to forget about the potential of evening primrose oil in this regard.
In a study combining evening primrose oil and fish oil supplementation,
blood pressure was significantly lowered when compared to evening primrose
oil plus sunflower and evening primrose oil plus flax oil.17
Osteoporosis
It appears evident from the published research that we must expand our
use of EFAs to maximize calcium metabolism and preserve bone health.
There is a growing body of evidence and research to warrant advice about
EFAs and calcium metabolism, bone health and the prevention of osteoporosis.
EFAs have been shown to increase calcium absorption from the gut (in
part by enhancing the effects of vitamin D), reduce urinary excretion
of calcium, increase calcium that is deposited in the bone and improve
the strength of bone.18 Adults with osteoporosis who are given fish
oil show an increase in calcium levels and an increase in urinary calcium
clearance.19 GLA in particular has been shown to reduce the excretion
of calcium20, inhibit bone reabsorption and markers of bone turnover
while at the same time increasing the levels of calcium content in the
bone.21
Ulcerative Colitis
Evening primrose oil has been studied for individuals with ulcerative
colitis. Although evening primrose oil did not reduce rectal bleeding
or stool frequency, it did significantly improve the stool consistency.22
Evening primrose oil and other EFA supplements may prove to have a long
term role in managing the symptoms of ulcerative colitis as well as
the underlying chronic inflammatory condition. We look forward to more
research in this area.
Other Effects
Brain function: A study of psychiatric patients with tardive
dyskinesia (abnormal involuntary movements) received evening primrose
oil capsules over four months. Although evening primrose oil supplementation
did not improve the abnormal movements, there was significant improvement
in mental state, schizophrenic symptoms and memory. In a second phase,
zinc, niacin and vitamins C and B6 were added to evening primrose oil.
The combination of supplements yielded marked and significant improvements
in memory, schizophrenic symptoms and abnormal movement.23, 24, 25
Alcoholism: In a
clinical trial of alcoholics withdrawing from alcohol, evening primrose
oil significantly reduced the severity of the withdrawal syndrome and
improved liver function as well. In individuals who did not relapse,
subjects reported improved memory and visual motor coordination while
taking evening primrose oil supplementation.26
Kidney transplants:
In a clinical trial of 89 kidney transplant patients who received either
evening primrose oil or placebo along with their standard immunosuppressive
medication, graft survival was significantly better in the evening primrose
oil group compared to placebo within the first 3-4 months.27
Safety and Side Effects
Minor side effects that may occur with evening primrose oil supplementation
include nausea, upset stomach and loose bowel movements.
These side effects may be
minimized by taking supplements with food or milk, taking the daily
dose in divided portions and increasing the dose slowly.
No problems have been associated
with pregnancy or breast feeding while supplementing with evening primrose
oil.
As with any nutritional supplement,
you are advised to consult with your health care practitioner before
beginning a supplementation program.
References:
- Jakubowica D. The significance
of prostaglandins in the pre- menstrual syndrome. In: Taylor R, ed.
Premenstrual syndrome. London: Medical New-Tribune, 1983, p.16.
- Puolakka J, et al. Biochemical
and clinical effects of treating the premenstrual syndrome with prostaglandin
synthesis pre- cursors. Journal of Reproductive Medicine, 1985;30(3):149-
153.
- Ocerman P, et al. Evening
primrose oil as a treatment of the premenstrual syndrome. Recent Advancements
in Clinical Nutrition,1986;2:404-405.
- Casper R, A double blind
trial of evening primrose oil in pre- menstrual syndrome. 2nd International
Symposium on PMS, Kiawah Island, Sept. 1987.
- Pye J, et al. Clinical
experience of drug treatment for mastal- gia. Lancet, 1985;2:373-377.
- Pashby N, et al. A clinical
trial of evening primrose oil in mastalgia. British Journal of Surgery,
1981;68:801-824.
- Chenoy R, Hussain S, Tayob
Y, O'Brien PM, Moss MY, Morse PF. Effect of oral gamolenic acid from
evening primrose oil on menopausal flushing. British Medical Journal,
1994 Feb 19; 308(6927):501-503.
- DıAlmeida A, Carter J,
Anatol A, Prost C. Women and Health, 1992;19(2/3):117-131.
- Morse P, Horrobin D, Manku
M. Meta-analysis of placebo- controlled studies of the efficacy of
Evening primrose oil (Epogam in the treatment of atopic eczema. Relationship
between plasma essential fatty acid changes and clinical response.
British Journal of Dermatology, 1989; 121:75-90.
- Yasumoto R, Fujita H,
Yamamoto T. The effectiveness, safety and usefulness of borage oil
on atopic dermatitis. Acta Dermatologica, 1996;92(2):249-251.
- Pullman-Mooar S, Laposata
M, Lem D, et al. Alteration of the cellular fatty acid profile and
the production of eicosanoids in human monocytes by gamma-linolenic
acid. Arthritis and Rheumatism, 1990;33(10):1526-1533.
- Andreassi M, Forleo P,
DiLorio A, et al. Efficacy of gamma- linolenic acid in the treatment
of patients with atopic der- matitis. Journal of International Medical
Research, 1997; 25:266-274.
- Zurier R, Rosetti R, Jacobson
E, et al. Gamma linolenic acid treatment of Rheumatoid Arthritis.
A randomized placebo- controlled trial. Arthritis Rheumatology, 1996;
39(11):1808- 1817.
- Leventhal L, Boyce E,
Zurier R. Treatment of Rheumatoid Arthritis with gamma-linolenic acid.
Annals of Internal Medicine, 1993;119:867-873.
- Keen H, et al. Treatment
of diabetic neuropathy with gamma linolenic acid. Diabetes Care, 1993;16:8-13.
- Guivernau M, Meza N,
Barja P, et al. Prostaglandins Leukotrienes and Essential Fatty Acids,
1994;51(5):311-316.
- Venter C, Joubert P, Booyens
J. Prostaglandins Leukotrienes and Essential Fatty Acids, 1988;33(1):49-51.
- Horrobin K. Calcium metabolism,
osteoporosis and essential fatty acids: a review. Progress in Lipid
Research, 1997;36(2- 3):131-151
- Papendorp D, Coetzer H,
Kruger M. Biochemical profile of osteoporotic patients on essential
fatty acid supplementation. Nutrition Research, 1995;15(3):325-334.
- Tulloch I, Smellie W,
Buck A. Evening primrose oil reduces uri- nary calcium excretion in
both normal and hypercalciuric rats. Urological Research, 1994;22:227-230.
- Claasen N, Potgieter M,
Seppa M, et al. Combination of evening primrose oil and fish oil influence
bone resorption and bone calcium content. Bone, 1995;16(Suppl):385S-392S.
- Greenfield S, Green A,
Teare J, et al. Alimentary Pharmacology and Therapeutics, 1993;7(2):159-166.
- Vaddadi K. Prostaglandins
Leukotrienes and Essential Fatty Acids, 1992;46(1):67-70.
- Vaddadi K, Courtney P,
Gilleard C, et al. Psychiatry Research, 1989;27(3):313-323.
- Vaddadi K. Prostaglandins
Leukotrienes and Essential Fatty Acids, 1996;55(102):89-94.
- Horrobin D. Review of
Contemporary Pharmacotherapy, 1990;1:1-45.
- McHugh M, Wilkinson R,
Elliott R, et al. Transplantation, 1977;24(4):263-267.
Browse Library Item List
|